BioCentury
ARTICLE | Emerging Company Profile

IntroGene B.V.

August 11, 1997 7:00 AM UTC

Leiden, the Netherlands

Technology: Gene therapy based on adenoviral, adeno-associated viral and retroviral vectors and modified hematopoietic stem cells...